Procainamide Gene Set

Dataset DrugBank Drug Targets
Category physical interactions
Type drug
Description 4-Aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias. (Chemical Entities of Biological Interest Ontology, CHEBI_8428)
External Link http://www.drugbank.ca/drugs/DB01035
Similar Terms
Downloads & Tools

Genes

8 interacting proteins for the Procainamide drug from the curated DrugBank Drug Targets dataset.

Symbol Name
BCHE butyrylcholinesterase
DNMT1 DNA (cytosine-5-)-methyltransferase 1
SCN5A sodium channel, voltage gated, type V alpha subunit
SLC22A1 solute carrier family 22 (organic cation transporter), member 1
SLC22A2 solute carrier family 22 (organic cation transporter), member 2
SLC22A3 solute carrier family 22 (organic cation transporter), member 3
SLC22A4 solute carrier family 22 (organic cation/zwitterion transporter), member 4
SLC22A5 solute carrier family 22 (organic cation/carnitine transporter), member 5